Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 20

1.
2.

A randomized multicenter Phase II study of perioperative tiotropium intervention in gastric cancer patients with chronic obstructive pulmonary disease.

Fushida S, Oyama K, Kaji M, Hirono Y, Kinoshita J, Tsukada T, Nezuka H, Nakano T, Noto M, Nishijima K, Fujimura T, Ohta T.

Int J Chron Obstruct Pulmon Dis. 2015 Oct 12;10:2177-83. doi: 10.2147/COPD.S89098. eCollection 2015.

3.

PAR1 participates in the ability of multidrug resistance and tumorigenesis by controlling Hippo-YAP pathway.

Fujimoto D, Ueda Y, Hirono Y, Goi T, Yamaguchi A.

Oncotarget. 2015 Oct 27;6(33):34788-99. doi: 10.18632/oncotarget.5858.

4.

Expression of prokineticin-receptor2(PK-R2) is a new prognostic factor in human colorectal cancer.

Goi T, Kurebayashi H, Ueda Y, Naruse T, Nakazawa T, Koneri K, Hirono Y, Katayama K, Yamaguchi A.

Oncotarget. 2015 Oct 13;6(31):31758-66. doi: 10.18632/oncotarget.5565.

5.

The prognosis was poorer in colorectal cancers that expressed both VEGF and PROK1 (No correlation coefficient between VEGF and PROK1).

Goi T, Nakazawa T, Hirono Y, Yamaguchi A.

Oncotarget. 2015 Oct 6;6(30):28790-9. doi: 10.18632/oncotarget.4744.

6.

Prokineticin 2 (PROK2) is an important factor for angiogenesis in colorectal cancer.

Kurebayashi H, Goi T, Shimada M, Tagai N, Naruse T, Nakazawa T, Kimura Y, Hirono Y, Yamaguchi A.

Oncotarget. 2015 Sep 22;6(28):26242-51. doi: 10.18632/oncotarget.4385.

7.

Randomized Phase II trial of paclitaxel plus valproic acid vs paclitaxel alone as second-line therapy for patients with advanced gastric cancer.

Fushida S, Kaji M, Oyama K, Hirono Y, Nezuka H, Takeda T, Tsukada T, Fujimoto D, Ohyama S, Fujimura T, Ohta T.

Onco Targets Ther. 2015 Apr 23;8:939-41. doi: 10.2147/OTT.S83114. eCollection 2015.

8.

The anti-tumor effect is enhanced by simultaneously targeting VEGF and PROK1 in colorectal cancer.

Goi T, Nakazawa T, Hirono Y, Yamaguchi A.

Oncotarget. 2015 Mar 20;6(8):6053-61.

9.

CD44variant exon 9 plays an important role in colon cancer initiating cells.

Kimura Y, Goi T, Nakazawa T, Hirono Y, Katayama K, Urano T, Yamaguchi A.

Oncotarget. 2013 May;4(5):785-91.

10.

Five-year survival of alpha-fetoprotein-producing gastric cancer with synchronous liver metastasis: a case report.

Koneri K, Hirono Y, Fujimoto D, Sawai K, Morikawa M, Murakami M, Goi T, Iida A, Katayama K, Yamaguchi A.

J Gastric Cancer. 2013 Mar;13(1):58-64. doi: 10.5230/jgc.2013.13.1.58. Epub 2013 Mar 31.

11.

Phase I/II study of intraperitoneal docetaxel plus S-1 for the gastric cancer patients with peritoneal carcinomatosis.

Fushida S, Kinoshita J, Kaji M, Hirono Y, Goda F, Yagi Y, Oyama K, Sudo Y, Watanabe Y, Fujimura T; Society for Study of Peritoneal Carcinomatosis in Gastric Cancer.

Cancer Chemother Pharmacol. 2013 May;71(5):1265-72. doi: 10.1007/s00280-013-2122-0. Epub 2013 Feb 20.

12.

Polysaccharide K suppresses angiogenesis in colon cancer cells.

Satoh Y, Goi T, Nakazawa T, Kimura Y, Hirono Y, Katayama K, Yamaguchi A.

Exp Ther Med. 2012 Sep;4(3):370-374. Epub 2012 Jul 4.

13.

Formation of Ga droplets on patterned GaAs (100) by molecular beam epitaxy.

Li MY, Hirono Y, Koukourinkova SD, Sui M, Song S, Kim ES, Lee J, Salamo GJ.

Nanoscale Res Lett. 2012 Oct 3;7(1):550. doi: 10.1186/1556-276X-7-550.

14.

MUC2 protein expression status is useful in assessing the effects of hyperthermic intraperitoneal chemotherapy for peritoneal dissemination of colon cancer.

Fujishima Y, Goi T, Kimura Y, Hirono Y, Katayama K, Yamaguchi A.

Int J Oncol. 2012 Apr;40(4):960-4. doi: 10.3892/ijo.2012.1334. Epub 2012 Jan 16.

15.

The activation of Proteinase-Activated Receptor-1 (PAR1) mediates gastric cancer cell proliferation and invasion.

Fujimoto D, Hirono Y, Goi T, Katayama K, Matsukawa S, Yamaguchi A.

BMC Cancer. 2010 Aug 19;10:443. doi: 10.1186/1471-2407-10-443.

16.

Jungle honey enhances immune function and antitumor activity.

Fukuda M, Kobayashi K, Hirono Y, Miyagawa M, Ishida T, Ejiogu EC, Sawai M, Pinkerton KE, Takeuchi M.

Evid Based Complement Alternat Med. 2011;2011:908743. doi: 10.1093/ecam/nen086. Epub 2010 Oct 19.

17.

Expression of autocrine motility factor receptor correlates with disease progression in human gastric cancer.

Hirono Y, Fushida S, Yonemura Y, Yamamoto H, Watanabe H, Raz A.

Br J Cancer. 1996 Dec;74(12):2003-7.

18.

DNA polymerase alpha positive-cell rate in colorectal cancer and its relationship to prognosis.

Yamaguchi A, Hirono Y, Fushida S, Kurosaka Y, Kanno M, Yonemura Y, Miyazaki I.

Br J Cancer. 1992 Mar;65(3):421-4.

19.

Mutations induced in Arabidopsis by DNA nucleoside analogs.

Hirono Y, Smith HH.

Genetics. 1969 Jan;61(1):191-9. No abstract available.

20.

INDUCED PREMEIOTIC EXCHANGE OF LINKED MARKERS IN THE ANGIOSPERM ARABIDOPSIS.

HIRONO Y, REDEI GP.

Genetics. 1965 Apr;51:519-26. No abstract available.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk